Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : La Jolla Diagnostics, Inc.(OTC BB: LAJD) -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (125)	12/8/1999 10:46:00 AM
From: Madeleine Harrison	Respond to of 168

beautiful, just beautiful news. I wonder what else they have cooking? Stock moving up on 4 times average volume. .16/.19 --Madly (COMTEX) B: La Jolla Diagnostics' Subsidiary DiagnosTech Inc. Products Used in South African HIV Tests LA JOLLA, Calif., Dec 8, 1999 (BW HealthWire) -- La Jolla Diagnostics Inc. (OTCBB:LAJD), announced today that its subsidiary DiagnosTech's rapid diagnostic test for HIV Types 1&2 is now available nationally to the entire South African public via pharmacies. The test is being packaged and distributed by Alton Health International, a prominent South African firm. Alton Health has begun a national advertising campaign to announce the over the counter availability of the test throughout South Africa. DiagnosTech's specially designed rapid diagnostic test for HIV is particularly suited for the environmental conditions found in Africa, because it is easy to use, and maintains its sensitivity even when subjected to extreme changes in temperature and humidity. According to a joint United Nations, World Health Organization report, over 34 million people worldwide are infected with HIV. Two thirds of them are in Sub-Saharan Africa, including 70% of the new cases reported in 1998. The majority of the newly infected are young people under the age of 24. La Jolla Diagnostics is an emerging company engaged in the development and marketing of state-of-the-art diagnostic tests (including a proprietary test for active tuberculosis), health care products and dietary supplements. The healthcare and dietary supplement products are formulated using proprietary technology. Copyright (C) 1999 Business Wire. All rights reserved. Distributed via COMTEX. -0- CONTACT: La Jolla Diagnostics Inc. 800/454-6790 lajd.com lajd96@aol.com WEB PAGE: businesswire.com GEOGRAPHY: CALIFORNIA INTERNATIONAL AFRICA/MIDDLE EAST INDUSTRY CODE: MEDICAL MEDICAL